Versor Investments LP and Levin Capital Strategies L.P. are amongst several organisations noticeably increasing their shares in Bunge Global SA BG. Other investors such as TIAA Trust National Association and the Bank of Montreal have trimmed their position, creating a mixed investment scenario. This follows Bunge's strong Q3 2025 reports with an EPS outlook for 2025 at $7.30–$7.60, revenues surging year by year (Y/Y), aided by the Viterra acquisition. Barclays upgraded its rating for Bunge following the Q3 results, with JPMorgan adjusting the price target to $109 from $107. The Viterra merger also achieved conditional approval from China aiding Bunge's positive financial standing. Despite the promising results, Bunge's Q3 profit fell but sales increased, indicating a potential margin improvement in the company. The future outlook appears hopeful as Bunge edges closer to its post-merger performance. However, there are speculations of Bunge Global stock underperforming the Nasdaq, but overall, Wall Street seems bullish on Bunge Global Stock.
Bunge Global Sa BG News Analytics from Tue, 28 Jan 2025 08:00:00 GMT to Sat, 08 Nov 2025 11:49:10 GMT -
